Literature DB >> 15695242

Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1.

Xiangbin Wang1, Rosa Linda Miyares, Gerard P Ahern.   

Abstract

Oleoylethanolamide (OEA) is an endogenous lipid that regulates feeding and body weight. Although the effects of OEA are believed to depend on activation of vagal sensory afferent neurones, the mechanisms involved in exciting these neurones are unclear. Here we show that OEA directly excited nodose ganglion neurones, the cell bodies of vagal afferents. OEA depolarized these neurones and evoked inward currents that were restricted to capsaicin-sensitive cells. These currents were fully blocked by the TRPV1 inhibitor, capsazepine, and no responses to OEA were observed in neurones cultured from TRPV1-null mice. Similarly, OEA induced a rise in Ca(+) concentration in wild-type but not TRPV1-deficient neurones, and responses to OEA were greater at 37 degrees C compared to room temperature. Significantly, OEA administration in mice induced visceral pain-related behaviours that were inhibited by capsazepine and absent in TRPV1-null animals. Further, OEA reduced 30-min food intake in wild-type but not in TRPV1-null mice. Thus, the acute behavioural effects of OEA may result from visceral malaise via the activation of TRPV1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695242      PMCID: PMC1464447          DOI: 10.1113/jphysiol.2004.081844

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  19 in total

Review 1.  The vanilloid receptor: a molecular gateway to the pain pathway.

Authors:  M J Caterina; D Julius
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Effects of red pepper on appetite and energy intake.

Authors:  M Yoshioka; S St-Pierre; V Drapeau; I Dionne; E Doucet; M Suzuki; A Tremblay
Journal:  Br J Nutr       Date:  1999-08       Impact factor: 3.718

Review 3.  Vanilloid (Capsaicin) receptors and mechanisms.

Authors:  A Szallasi; P M Blumberg
Journal:  Pharmacol Rev       Date:  1999-06       Impact factor: 25.468

4.  Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia.

Authors:  J B Davis; J Gray; M J Gunthorpe; J P Hatcher; P T Davey; P Overend; M H Harries; J Latcham; C Clapham; K Atkinson; S A Hughes; K Rance; E Grau; A J Harper; P L Pugh; D C Rogers; S Bingham; A Randall; S A Sheardown
Journal:  Nature       Date:  2000-05-11       Impact factor: 49.962

5.  Involvement of vanilloid receptor VR1 and prostanoids in the acid-induced writhing responses of mice.

Authors:  Y Ikeda; A Ueno; H Naraba; S Oh-ishi
Journal:  Life Sci       Date:  2001-11-02       Impact factor: 5.037

6.  Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide.

Authors:  Silvana Gaetani; Fariba Oveisi; Daniele Piomelli
Journal:  Neuropsychopharmacology       Date:  2003-04-02       Impact factor: 7.853

7.  Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide.

Authors:  V Vellani; S Mapplebeck; A Moriondo; J B Davis; P A McNaughton
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

8.  In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.

Authors:  Laszlo Urban; Elizabeth A Campbell; Moh Panesar; Sadhana Patel; Naureen Chaudhry; Steven Kane; Karl-Heinz Buchheit; Barrie Sandells; Iain F James
Journal:  Pain       Date:  2000-12-15       Impact factor: 6.961

9.  An anorexic lipid mediator regulated by feeding.

Authors:  F Rodríguez de Fonseca; M Navarro; R Gómez; L Escuredo; F Nava; J Fu; E Murillo-Rodríguez; A Giuffrida; J LoVerme; S Gaetani; S Kathuria; C Gall; D Piomelli
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

10.  Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxin.

Authors:  Michela Rigoni; Marcello Trevisani; David Gazzieri; Riccardo Nadaletto; Michele Tognetto; Christophe Creminon; John B Davis; Barbara Campi; Silvia Amadesi; Pierangelo Geppetti; Selena Harrison
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

View more
  62 in total

1.  Infrared heat treatment reduces food intake and modifies expressions of TRPV3-POMC in the dorsal medulla of obesity prone rats.

Authors:  Jay Hu; Hyunwoo June Choo; Sheng-Xing Ma
Journal:  Int J Hyperthermia       Date:  2011-10-03       Impact factor: 3.914

Review 2.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

3.  Evaluation of fatty acid amides in the carrageenan-induced paw edema model.

Authors:  Laura E Wise; Roberta Cannavacciulo; Benjamin F Cravatt; Billy F Martin; Aron H Lichtman
Journal:  Neuropharmacology       Date:  2007-06-22       Impact factor: 5.250

Review 4.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 5.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.

Authors:  Gilliard Lach; Harriet Schellekens; Timothy G Dinan; John F Cryan
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

6.  Gastrointestinal hormones and the dialogue between gut and brain.

Authors:  Graham J Dockray
Journal:  J Physiol       Date:  2014-02-24       Impact factor: 5.182

7.  Synthesis and characterization of the first inhibitor of N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD).

Authors:  Beatrice Castellani; Eleonora Diamanti; Daniela Pizzirani; Piero Tardia; Martina Maccesi; Natalia Realini; Paola Magotti; Gianpiero Garau; Thomas Bakkum; Silvia Rivara; Marco Mor; Daniele Piomelli
Journal:  Chem Commun (Camb)       Date:  2017-11-28       Impact factor: 6.222

Review 8.  The role of endogenous molecules in modulating pain through transient receptor potential vanilloid 1 (TRPV1).

Authors:  Sara L Morales-Lázaro; Sidney A Simon; Tamara Rosenbaum
Journal:  J Physiol       Date:  2013-04-22       Impact factor: 5.182

9.  Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.

Authors:  Zhongyi Chen; Lilu Guo; Yongqin Zhang; Rosemary L Walzem; Julie S Pendergast; Richard L Printz; Lindsey C Morris; Elena Matafonova; Xavier Stien; Li Kang; Denis Coulon; Owen P McGuinness; Kevin D Niswender; Sean S Davies
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

10.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.